相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Generic sodium stibogluconate is as safe and effective as branded meglumine antimoniate, for the treatment of tegumentary leishmaniasis in Isiboro Secure Park, Bolivia
H. Bermudez et al.
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY (2006)
Liposomal amphotericin B for the treatment of visceral leishmaniasis
Caryn Bern et al.
CLINICAL INFECTIOUS DISEASES (2006)
A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection
K Ritmeijer et al.
CLINICAL INFECTIOUS DISEASES (2006)
A comparative evaluation of amphotericin B and sodium antimony gluconate, as first-line drugs in the treatment of Indian visceral leishmaniasis
CP Thakur et al.
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY (2004)
Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline
S Rijal et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2003)
A policy for leishmaniasis with respect to the prevention and control of drug resistance
A Bryceson
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2001)
Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome
K Ritmeijer et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2001)
Nephrotoxicity of amphotericin B desoxycholate
C Girmenia et al.
CLINICAL INFECTIOUS DISEASES (2001)
Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial
U Eriksson et al.
BMJ-BRITISH MEDICAL JOURNAL (2001)
A randomized comparison of branded sodium stibogluconate and generic sodium stibogluconate for the treatment of visceral leishmaniasis under field conditions in Sudan
H Veeken et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2000)
分享论文
